emtricitabine 200 mg tenofovir disoproxil fumarate 300 mg
1 INDICATIONS AND USAGE HIV-1 Treatment ( 1.1 ) Emtricitabine and tenofovir disoproxil fumarate tablets are two-drug combination of emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF), both HIV-1 nucleoside analog reverse transcriptase inhibitors, and is indicated: in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 17 kg. HIV-1 PrEP ( 1.2 ): Emtricitabine and tenofovir disoproxil fumarate tablets are indicated in at-risk adults and adolescents weighing at least 35 kg for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection. Individuals must have a negative HIV-1 test immediately prior to initiating emtricitabine and tenofovir disoproxil fumarate tablets for HIV-1 PrEP. 1.1 Treatment of HIV-1 Infection Emtricitabine and tenofovir disoproxil fumarate tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 17 kg [see Clinical Studies ( 14 )] . 1.2 HIV-1 Pre-Exposure Prophylaxis (PrEP) Emtricitabine and tenofovir disoproxil fumarate tablets are indicated in at-risk adults and adolescents weighing at least 35 kg for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection. Individuals must have a negative HIV-1 test immediately prior to initiating emtricitabine and tenofovir disoproxil fumarate tablets for HIV-1 PrEP [see Dosage and Administration ( 2.2 ), Warnings and Precautions ( 5.2 )] .
Zydus Pharmaceuticals (USA) Inc.
OVAL WHITE 1367
Related Pills
probenecid 500 MG Oral Tablet
Marlex Pharmaceuticals Inc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, 100 mg of FTC and 150 mg of TDF (equivalent to 123 mg of tenofovir disoproxil) are white to off-white-colored, oval-shaped, film-coated tablets, debossed with "1364" on one side and plain on other side and are supplied as follows: NDC 70710-1364-3 in bottles of 30 tablets with child-resistant closure NDC 70710-1364-9 in bottles of 90 tablets with child-resistant closure NDC 70710-1364-4 in unit-dose blister cartons of 100 tablets (10 x 10 unit-dose)
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, 133 mg of FTC and 200 mg of TDF (equivalent to 163 mg of tenofovir disoproxil) are white to off-white-colored, rectangular-shaped, film-coated tablets, debossed with "1365" on one side and plain on other side and are supplied as follows: NDC 70710-1365-3 in bottles of 30 tablets with child-resistant closure NDC 70710-1365-9 in bottles of 90 tablets with child-resistant closure NDC 70710-1365-4 in unit-dose blister cartons of 100 tablets (10 x 10 unit-dose)
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, 167 mg of FTC and 250 mg of TDF (equivalent to 204 mg of tenofovir disoproxil) are white to off-white-colored, modified capsule-shaped, film-coated tablets, debossed with "1366" on one side and plain on other side and are supplied as follows: NDC 70710-1366-3 in bottles of 30 tablets with child-resistant closure NDC 70710-1366-9 in bottles of 90 tablets with child-resistant closure NDC 70710-1366-4 in unit-dose blister cartons of 100 tablets (10 x 10 unit-dose)
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE tablets, 200 mg of FTC and 300 mg of TDF (equivalent to 245 mg of tenofovir disoproxil) are white to off-white-colored, capsule-shaped, film-coated tablets, debossed with "1367" on one side and plain on other side and are supplied as follows: NDC 70710-1367-3 in bottles of 30 tablets with child-resistant closure NDC 70710-1367-9 in bottles of 90 tablets with child-resistant closure NDC 70710-1367-4 in unit-dose blister cartons of 100 tablets (10 x 10 unit-dose) Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Keep container tightly closed Dispense only in original container
More pills like OVAL 1367